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PENGOPTIMUMAN DAN BIOSERASI PERANCAH BUSA ALUMINA 
BERSALUT BAGI APLIKASI KEJURUTERAAN TISU TULANG  
 
ABSTRAK 
Perancah busa alumina (AF) bersalut adalah salah satu bio sintetik yang mendapat 
perhatian daripada ahli-ahli sains bahan bagi mengatasi sifat lengai supaya interaksi 
ikatan tisu tulang dipertingkatkan. Kajian ini bertujuan untuk menghasilkan AF 
bersalut dengan kekuatan mampatan yang lebih tinggi daripada 2 MPa kepada 12 
MPa, keliangan yang lebih tinggi daripada 70% kepada 99% dan saiz liang yang 
besar daripada 100 µm hingga 1000 µm yang diperlukan dalam aplikasi kejuruteraan 
tisu tulang.  Faktor- faktor penting dalam teknik replikasi busa polimer (PFR) adalah 
jumlah liang (ppi) busa polimer (PU),  nisbah komposisi pepejal kepada air ternyah-
ion, peratusan pengikat dan kekerapan proses mecelup. Analisis DOE menggunakan  
rekabentuk pecahan 2
k
 faktorial menunjukkan jumlah liang, nisbah komposisi dan 
bilangan mencelup adalah faktor terpenting mempengaruhi kekuatan mampatan 
perancah AF. Merujuk kepada rekabentuk kiub berpusat muka (FCC), nisbah 
komposisi 60/40, 20 ppi bilangan liang dan tiga kali proses mencelup adalah syarat 
yang memenuhi untuk perancah tulang manusia. Perancah AF dipertingkatkan 
dengan salutan hidroksiapatit (HACAF) dan hidroksiapatit-bentonit (HABCAF). 
Sampel-sample dinilai oleh analisis in-vitro iaitu rendaman di dalam simulasi cecair 
badan (SBF) dan ujian sitotosik (MTS assay). Analisis in-vitro menunjukkan 
permukaan perancah HACAF dan HABCAF mempunyai lapisan mendakan apatit 
dan kesan pertumbuhan sel yang positif.  
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OPTIMIZATION AND BIOCOMPATIBILITY OF ALUMINA FOAM 
COATED SCAFFOLD FOR BONE TISSUE ENGINEERING APPLICATION 
 
ABSTRACT 
Alumina foam (AF) coated scaffold is one of synthetics biomaterials that has 
received much attention to overcome inertness properties for enhanced bone tissue 
bonding interaction. This research aims to produce AF coated scaffold with 
compressive strength higher than 2 MPa to 12 MPa, porosity higher than 70% to 
99% and pores size are larger than 100 µm to 1000 µm which required in bone tissue 
engineering application. The significant factors in polymer foam replication (PFR) 
techniques are number of pores (ppi) of polyurethane (PU) foam, the composition 
ratio of solid loading to deionized water, percentage of binder and number of dipping 
process. The DOE analysis using 2
k
 fractional factorial designs shows that the 
number of pore, composition ratio and number of dipping are most significant factors 
effect on the compressive strength of AF scaffold. According to the face-centered 
cube (FCC) design, the condition satisfied for human bone scaffold is prepared at 
60/40 composition ratio, 20 ppi numbers of pores and three times of dipping process. 
The AF scaffold was further improved by coated with hydroxyapatite (HACAF) and 
hydroxyapatite-bentonite (HABCAF). The samples were evaluated by in-vitro 
analysis which is immersed in simulated body fluid (SBF) solution and cytotoxicity 
by MTS assay. The in-vitro analysis showed the surface of HACAF and HABCAF 
scaffold have precipitations of apatite layer and positive effect on cell growth. 
1 
 
CHAPTER 1 
 
INTRODUCTION 
 
1.1 Background of the Study 
Human body is a perfect creation. It is a combination of many structural, 
cellular and functional levels in one-well organized unit. The structural elements of 
the human body are bones. Bones can be defined as a vascularised structure of living 
cells (Hench, 1996; Lickorish et al., 2007). Besides providing an internal structural 
framework for the body, bones also protect the internal organs, and are a reservoir 
for minerals that serve a metabolic function. 
Being hard and strong does not mean that bones do not get injured. Bone 
injuries such as fractures and slips, are now more prevalent in numbers. Alarmingly, 
over 70,000 hip fractures occur in the UK and estimated 7.9 million patients 
suffering fractures in the USA annually (Victoria et al., 2009; Patel et al., 2013). The 
increasing numbers are due to several reasons. For example, an increase in life 
expectancy, i.e., age increase will result in reduced the bone density, causing 
decrease in bone strength, allowing easier fracture. Increased amounts of trauma 
cases, largely due to motor vehicle accidents and other mishaps is arguably another 
major contributor. Other than couple, diseases (such as Paget’s disease and even 
cancer) and failures to heal (non-unions) also contributed to the increasing numbers 
of bone injuries. For example, approximately 10% of fracture cases in the USA 
resulted in non-unions and/ or delayed unions; the number tends to be higher in 
developing countries. Thus, widespread attention was focused on bone repair, up to a 
point that WHO has declared that year 2000 to 2010 as the Bone and Joint Decade 
(Lidgren, 2003). Current clinical bone repair strategies (i.e., autografts, allografts and 
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insertion of man-made materials) are associated with various bone problems. 
Autografts, although being the most reliable technique, however it is exhibit 
significant limitations, such as lack of sources (limited transplantable option), donor 
site morbidity and cellular reactions such as inflammation. Allografts meanwhile, are 
accountable for poor osteoconductivity and immune responses. As for man-made 
materials, leaving a foreign material in the body is perhaps not the best solution. This 
is where bone tissue engineering (BTE) comes into the scene (Gomes and Reis, 
2004; Jones and Hench, 2003). 
Since mid-80s, BTE becomes exciting field with extreme potential in the 
future. Shalak and Fox (1988), and Sachlos and Czernuszka (2003), describes TE as 
multidisciplinary research, combining multiple areas of research such as 
mathematics, engineering and biology to restore of repair tissue function. Not only 
for cellular level repairs, tissue engineering (TE) is also hoped to find and develop 
biological substitutes and cellular aids (e.g., scaffolds) to improve the quality of 
human life (Jones and Hench, 2003; Gomes and Reis, 2004).  
Scaffold act as a template and as an artificial extracellular matrix. A template 
should have ability to support the human weight with appropriate mechanical 
strength. The range of mechanical strength for cancellous types is between 2-12MPa 
to mimic the original bone (Takaoka et al., 1996; Ramay and Zhang, 2003; Vitale-
Brovarone et al., 2009). Besides, the scaffolds induced the formation of bone by 
guiding new tissue growth in three dimensionality (3D) structure. The 3D structure 
with porosity in a range of 50 to 90% is suggested to simulate an extracellular 
function closely (i.e., nutrient transportation, waste removal and gas diffusion) 
(Hutmacher, 2000; Vitale-Brovarone et al., 2007; Bellucci et al., 2011). In addition, 
scaffold should exhibit pore diameter size higher than 100μm as requirement for 
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osteoinduction process (Jun et al., 2003). The osteoinduction stimulates osteogenesis 
dependent on the surface materials response. Thus, the materials of scaffold must be 
biocompatible with the host tissue for cell-materials interaction. The findings were 
proved that ceramic materials have biocompatible chemical composition for 
implantable in human body (Hench, 1996). 
Some of ceramic materials are classified as biomaterials. Biomaterials can be 
categorized into natural or synthetic materials that are suitable for implantable in 
human body (Chevalier and Gremillard, 2009). Ceramic is exhibiting good response 
to human body according to their various properties such as chemical reactivity, 
biocompatibility and resorbable. For example, alumina (Al2O3) and zirconia (ZrO2) 
have been widely used in BTE field (Miao et al., 2007; Yang et al., 2011). Both 
having high mechanical strength, high density and high wear resistance. It also 
promotes excellent result from load bearing application. Alumina is suggested as the 
most widely used in orthopaedic applications due to minimum tissue rejection after 
implantation. Unfortunately, alumina has inherently an inertness property which does 
not support cell proliferation. Therefore, alumina coated with HAp has been working 
since 1995 to enhance bone bonding interaction (Takaoka et al., 1996). The bioactive 
silica glasses, hydroxyapatite (HAp) and tri-calcium phosphate (TCP) shows good 
sign of biological response at the interface of material and encourage the growth of 
new bone (Yang et al., 2011). Other than that, bentonite also chosen as coating 
materials based on its influence on bioavailability, non-toxicity and various proof 
that it acts as good binding agent for excellent coating (Carretero, 2012).  
There are various fabrication techniques to produce porous biomaterials such 
as foaming consolidation, gel-casting, salt leaching, polymeric foam replication and 
rapid prototyping (Lyckfeldt and Ferreira,1998; Hou et al., 2003; Ryan et al., 2008; 
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Sopyan and Kaur, 2009). Control over fabrication route could help to obtain good 
implantable properties. Yet, it is still arguable which techniques are most excellent 
and pave an interesting route for design bone scaffold. Thus, polymer foam 
replication (PFR) was proposed as an effective technique to fabricate porous 
structure has been proven with controllable pore size, controllable interconnectivity 
and uniform pore size distribution (Lyckfeldt and Ferreira, 1998; Sopyan and Kaur, 
2009). Moreover, due to the low cost of polymer foam, the PFR is also known as 
profitable technique and economical (Colombo and Modesti, 1999). PFR is 
dependent on several factors which, properties of foam, the preparation of slurry and 
the fabrication parameters influenced the properties of scaffold (i.e., mechanical 
strength, porosity, pore diameter size, interconnectivity and biocompatibility). These 
properties play very important roles in nutrient transportation to encourage cell 
growth in 3D. 
The transportation of nutrient prediction performed through modelling 
approaches. Current modelling approaches for transportation involved various 
bioreactors design models for bone tissue growth for example hollow fibre 
membrane, confined perfusion bioreactor, and suspended tube bioreactor (Abdullah 
et al., 2009). The transport can be enhanced dependent on the types of bioreactor. For 
example, the transport restriction on batch system can be improved by addition of 
perfusion or by continuously refreshing the surrounding medium (Sengers et al., 
2005). Designing of bioreactor for tissue engineered is important to allow tissue 
formation in 3D by good support for cell attachment, proliferation and 
vascularisation as well as enabling sufficient nutrient supply to cells. Modelling is 
requires for optimization process by identifying the main governing processes for 
practical TE efforts. In order to meet the goal of improving nutrient transportation, 
